Biodiversity and human livelihood crises in the Malay Archipelago.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 17181817)

Published in Conserv Biol on December 01, 2006

Authors

Navjot S Sodhi1, Thomas M Brooks, Lian Pin Koh, Greg Acciaioli, Maribeth Erb, Alan Khee-Jin Tan, Lisa M Curran, Peter Brosius, Tien Ming Lee, Jason M Patlis, Melvin Gumal, Robert J Lee

Author Affiliations

1: Department of Biological Sciences, National University of Singapore, 14 Science Drive 4, Singapore 117543, Republic of Singapore. dbsns@nus.edu.sg

Articles by these authors

Effectiveness of the global protected area network in representing species diversity. Nature (2004) 10.66

Modelling conservation in the Amazon basin. Nature (2006) 9.07

The status of the world's land and marine mammals: diversity, threat, and knowledge. Science (2008) 8.03

Primary forests are irreplaceable for sustaining tropical biodiversity. Nature (2011) 6.85

The impact of conservation on the status of the world's vertebrates. Science (2010) 6.71

Southeast Asian biodiversity: an impending disaster. Trends Ecol Evol (2004) 6.11

Environment. Tropical forests and climate policy. Science (2007) 4.44

The value of the IUCN Red List for conservation. Trends Ecol Evol (2005) 4.25

Refractive error and ethnicity in children. Arch Ophthalmol (2003) 3.50

Conservation. Protected areas and effective biodiversity conservation. Science (2013) 3.42

A global assessment of endemism and species richness across island and mainland regions. Proc Natl Acad Sci U S A (2009) 3.36

Bringing the tiger back from the brink-the six percent solution. PLoS Biol (2010) 2.67

Pinpointing and preventing imminent extinctions. Proc Natl Acad Sci U S A (2005) 2.64

Committed carbon emissions, deforestation, and community land conversion from oil palm plantation expansion in West Kalimantan, Indonesia. Proc Natl Acad Sci U S A (2012) 2.59

Protecting important sites for biodiversity contributes to meeting global conservation targets. PLoS One (2012) 2.50

Measuring the meltdown: drivers of global amphibian extinction and decline. PLoS One (2008) 2.46

Hotspots and the conservation of evolutionary history. Proc Natl Acad Sci U S A (2002) 2.28

Ecology. China, India, and the environment. Science (2010) 2.27

Cost-effective global conservation spending is robust to taxonomic group. Proc Natl Acad Sci U S A (2008) 2.24

Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells. Blood (2008) 2.24

REDD: a reckoning of environment and development implications. Trends Ecol Evol (2010) 2.09

Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation. Cancer Cell (2012) 2.01

The sixth mass coextinction: are most endangered species parasites and mutualists? Proc Biol Sci (2009) 1.89

Prevalence, management, and outcomes of critically ill patients with prothrombin time prolongation in United Kingdom intensive care units. Crit Care Med (2010) 1.66

Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses. Cancer Res (2007) 1.60

Cautious optimism over Norway-Indonesia REDD pact. Conserv Biol (2010) 1.54

Soil nutrients affect spatial patterns of aboveground biomass and emergent tree density in southwestern Borneo. Oecologia (2007) 1.54

Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical. Blood (2007) 1.51

Navjot's nightmare revisited: logging, agriculture, and biodiversity in Southeast Asia. Trends Ecol Evol (2013) 1.48

Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes. J Control Release (2006) 1.45

Bitter and sweet taste receptors regulate human upper respiratory innate immunity. J Clin Invest (2014) 1.42

Survival and recurrence in nonmycosis fungoides primary cutaneous lymphoma. Cancer J (2009) 1.38

Scientific foundations for an IUCN Red List of ecosystems. PLoS One (2013) 1.38

Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2. Mol Pharm (2009) 1.37

Targeted drug delivery via folate receptors. Expert Opin Drug Deliv (2008) 1.33

Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia. Clin Cancer Res (2013) 1.30

Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil. J Pharm Pharm Sci (2007) 1.27

Agricultural intensification escalates future conservation costs. Proc Natl Acad Sci U S A (2013) 1.27

Warfare in biodiversity hotspots. Conserv Biol (2009) 1.26

Long-term reproductive behaviour of woody plants across seven Bornean forest types in the Gunung Palung National Park (Indonesia): suprannual synchrony, temporal productivity and fruiting diversity. Ecol Lett (2007) 1.25

Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid. Blood (2002) 1.22

Targeted delivery systems for oligonucleotide therapeutics. AAPS J (2009) 1.19

A novel Raji-Burkitt's lymphoma model for preclinical and mechanistic evaluation of CD52-targeted immunotherapeutic agents. Clin Cancer Res (2008) 1.17

Calcium homeostasis modulator 1 (CALHM1) is the pore-forming subunit of an ion channel that mediates extracellular Ca2+ regulation of neuronal excitability. Proc Natl Acad Sci U S A (2012) 1.16

A hyperspectral imaging system for in vivo optical diagnostics. Hyperspectral imaging basic principles, instrumental systems, and applications of biomedical interest. IEEE Eng Med Biol Mag (2004) 1.16

Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer. Mol Ther Nucleic Acids (2013) 1.14

Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes. Int J Pharm (2007) 1.14

Disparities between observed and predicted impacts of climate change on winter bird assemblages. Proc Biol Sci (2009) 1.13

Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor. Adv Drug Deliv Rev (2004) 1.12

Cholesterol as a bilayer anchor for PEGylation and targeting ligand in folate-receptor-targeted liposomes. J Pharm Sci (2007) 1.11

Receptor-targeted nanocarriers for therapeutic delivery to cancer. Mol Membr Biol (2010) 1.11

Red cell requirements for intensive care units adhering to evidence-based transfusion guidelines. Transfusion (2004) 1.08

Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine. J Control Release (2004) 1.08

A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Crit Care (2011) 1.04

A folate receptor-targeted liposomal formulation for paclitaxel. Int J Pharm (2006) 1.03

Tumour-selective drug delivery via folate receptor-targeted liposomes. Expert Opin Drug Deliv (2004) 1.03

Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations. J Control Release (2002) 1.02

Delivery of antisense oligodeoxyribonucleotide lipopolyplex nanoparticles assembled by microfluidic hydrodynamic focusing. J Control Release (2009) 1.02

Interleukin-17A induces bicarbonate secretion in normal human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol (2008) 1.01

Imaging receptor-mediated endocytosis with a polymeric nanoparticle-based coherent anti-stokes Raman scattering probe. J Phys Chem B (2007) 1.01

The bitter taste receptor T2R38 is an independent risk factor for chronic rhinosinusitis requiring sinus surgery. Int Forum Allergy Rhinol (2013) 1.00

Genetics of the taste receptor T2R38 correlates with chronic rhinosinusitis necessitating surgical intervention. Int Forum Allergy Rhinol (2013) 1.00

Positive relationships between association strength and phenotypic similarity characterize the assembly of mixed-species bird flocks worldwide. Am Nat (2012) 0.98

Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy. Bioconjug Chem (2003) 0.98

Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7alpha-APTADD to breast cancer cells. Int J Pharm (2010) 0.97

Lipid-coated nano-calcium-phosphate (LNCP) for gene delivery. Int J Pharm (2010) 0.97

Oil palm: disinformation enables deforestation. Trends Ecol Evol (2008) 0.97

Evaluation of chitosan salts as non-viral gene vectors in CHO-K1 cells. Int J Pharm (2007) 0.97

Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model. Pharm Res (2003) 0.97

Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy. Anticancer Agents Med Chem (2006) 0.97

Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma. Int J Nanomedicine (2012) 0.96

Nanoparticles as image enhancing agents for ultrasonography. Phys Med Biol (2006) 0.95

Thrombocytopenia and platelet transfusion in UK critical care: a multicenter observational study. Transfusion (2012) 0.95

Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor. Nanomedicine (2013) 0.95

Folate receptor-mediated targeting of liposomal drugs to cancer cells. Methods Enzymol (2004) 0.95

Role of formulation composition in folate receptor-targeted liposomal doxorubicin delivery to acute myelogenous leukemia cells. Mol Pharm (2007) 0.95

Lactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma. J Control Release (2013) 0.94

Conserving critical sites for biodiversity provides disproportionate benefits to people. PLoS One (2012) 0.94

Mass fruiting in Borneo: a missed opportunity. Science (2010) 0.93

Lipid nanoparticles for hepatic delivery of small interfering RNA. Biomaterials (2012) 0.93

Clinical translation of folate receptor-targeted therapeutics. Expert Opin Drug Deliv (2012) 0.92

Reconciling global mammal prioritization schemes into a strategy. Philos Trans R Soc Lond B Biol Sci (2011) 0.92

Milatuzumab immunoliposomes induce cell death in CLL by promoting accumulation of CD74 on the surface of B cells. Blood (2010) 0.92

A folate receptor-targeted lipid nanoparticle formulation for a lipophilic paclitaxel prodrug. Pharm Res (2004) 0.92

Synthesis of cetuximab-immunoliposomes via a cholesterol-based membrane anchor for targeting of EGFR. Bioconjug Chem (2007) 0.92

A novel pH-sensitive liposome formulation containing oleyl alcohol. Biochim Biophys Acta (2002) 0.91

Anemia during and at discharge from intensive care: the impact of restrictive blood transfusion practice. Intensive Care Med (2005) 0.91

AMPK supports growth in Drosophila by regulating muscle activity and nutrient uptake in the gut. Dev Biol (2010) 0.91

Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT). Bioconjug Chem (2006) 0.90

Targeted nanoparticles enhanced flow electroporation of antisense oligonucleotides in leukemia cells. Biosens Bioelectron (2010) 0.90

Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia. Blood (2012) 0.90

Synthesis of transferrin (Tf) conjugated liposomes via Staudinger ligation. Int J Pharm (2010) 0.90

Eradicating acute myeloid leukemia in a Mll(PTD/wt):Flt3(ITD/wt) murine model: a path to novel therapeutic approaches for human disease. Blood (2013) 0.90

Insight into mechanisms of cellular uptake of lipid nanoparticles and intracellular release of small RNAs. Pharm Res (2014) 0.90

Effects of high-frequency understorey fires on woody plant regeneration in southeastern Amazonian forests. Philos Trans R Soc Lond B Biol Sci (2013) 0.89

Folate receptor targeted delivery of liposomal daunorubicin into tumor cells. Anticancer Res (2002) 0.89